SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
MasterE
Lv7
1
3590 积分
2021-04-25 加入
最近求助
最近应助
互助留言
Survival outcome after surgery in patients with thymoma distant recurrence
1天前
已完结
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials
6天前
已完结
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
6天前
已完结
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)
6天前
已完结
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
6天前
已完结
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma
8天前
已完结
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050)
8天前
已完结
The dynamic role of platelets in cancer progression and their therapeutic implications
9天前
已完结
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
19天前
已完结
Gefitinib with or without pemetrexed in nonsquamous (NS) non-small cell lung cancer (NSCLC) with EGFR mutation (mut): Final overall survival (OS) results from a randomized phase II study
1个月前
已关闭
没有进行任何应助
已找到【积分已退回】
1个月前
帮大忙了
1年前
不是这篇
2年前
另找其他文献了【积分已退回】
2年前
找到了【积分已退回】
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论